Now accepting new clients across Iowa most insurance accepted.(319) 270-2890
Honest care for problematic psilocybin, DMT, and microdosing patterns, built on psychiatric evaluation and therapy, not a detox you do not need.
Radix Recovery provides psychedelic addiction treatment in Cedar Rapids, Iowa, for people whose use of psilocybin mushrooms, DMT, or daily microdosing has become something they cannot stop on their own. Psychedelics are not physically addictive the way opioids or alcohol are, and there is no withdrawal to detox from. The problem we treat is psychological dependence: relying on trips or microdoses to manage depression, anxiety, or daily life. We treat the use pattern and the condition underneath it together, with one clinical team, and admission is typically available within 24 hours.
Per NIDA, classic psychedelics do not cause compulsive drug-seeking or a physical withdrawal syndrome.
There is nothing to detox from. Care starts with stabilization and psychiatric evaluation instead.
The DSM-5 recognizes problematic use as hallucinogen use disorder, and it is treatable.
Problematic use usually masks untreated depression or anxiety, so we treat both together.
Last Reviewed
July 2026
Detox medications required Psychedelics produce no physical withdrawal syndrome. Treatment begins with stabilization and psychiatric evaluation, not a medication taper.
Dual diagnosis assessment A full psychiatric and substance use evaluation on arrival, because problematic psychedelic use usually masks untreated depression or anxiety.
Clinical support on site Round-the-clock staffing at our Cedar Rapids facility for residents whose anxiety, derealization, or polysubstance use needs close monitoring.
Is all it takes to start Our admissions team handles the details and moves you toward a bed as soon as one opens. Confidential from the first hello.
Here is what is also true: problematic psychedelic use is real, it is growing, and the DSM-5 recognizes it as hallucinogen use disorder. The pattern we treat is psychological dependence. You use mushrooms or DMT to escape, to feel insight, or to medicate depression and anxiety. Microdosing drifts from twice a week into every morning. You keep using despite lingering anxiety, derealization, strained relationships, or a frightening experience that has not fully left you.
That distinction shapes everything about how we treat it. There is no detox medication protocol on this page, because none is needed. What you will find instead is a treatment model built on psychiatric evaluation, integrated dual diagnosis care, and therapy that rebuilds what the substance was covering for.
Below, both halves of that honest answer sit side by side. You can lean into the medical facts or into the lived reality, but neither one cancels the other, and that is the entire point.
Not the way opioids or alcohol are. There is nothing here to detox from.
Psychological dependence is real, and it does not need a withdrawal to be serious.
Recognized by the DSM-5 as hallucinogen use disorder
Not the way opioids or alcohol are. There is nothing here to detox from.
Psychological dependence is real, and it does not need a withdrawal to be serious.
Recognized by the DSM-5 as hallucinogen use disorder
Not the way opioids or alcohol are. There is nothing here to detox from.
Psychological dependence is real, and it does not need a withdrawal to be serious.
The clinical line is not how often you trip. It is whether use has consequences and continues anyway, and whether you have lost the ability to function without it. Tap any line below that sounds like you or someone you love. Nothing is saved or shared. This is just a mirror.
What you noticed: risky behavior while tripping. That is worth a quiet conversation, not a verdict. A confidential call to (319) 270-2890 can help you make sense of it, with no pressure either way.
(319) 270-2890Speak With Admissions NowSpeak With Admissions NowIf you reached for psychedelics to feel better, the instinct was right even if the method stopped working. There is nothing to detox from here. Our job is to find what the substance was standing in for, and to treat that with you.
Chief Clinical Officer, Radix Recovery
We will not pretend the research is not promising. Clinical trials of psilocybin and other psychedelics for depression and end-of-life distress have produced genuinely hopeful results, and we take that work seriously. But there is a wide gap between a supervised clinical trial and buying a chocolate bar online, and that gap is exactly where harm happens. Expand each row to see how the two compare.
Participants are carefully screened for personal and family history of psychosis and bipolar disorder, the exact conditions psychedelics can unmask.
No screening of any kind. A vulnerability you do not know you carry meets a powerful drug with nobody checking first.
A precise, measured, pharmaceutical-grade dose is given, so the experience is calibrated rather than left to chance.
Gummies, bars, and grow kits carry unverified and inconsistent doses, so the same product can hit far harder than expected.
Trained clinicians are present throughout, ready to steady a session that turns frightening and to keep the person safe.
Often used alone or with friends who cannot help if panic, paranoia, or dangerous behavior takes over.
Structured preparation beforehand and guided integration afterward turn the experience into lasting therapeutic work.
No preparation and no integration, so a hard experience can leave lingering anxiety, derealization, or what clinicians call HPPD with nobody to help process it.
If you turned to psychedelics hoping to heal, that impulse made sense. The safe version of what you were reaching for is supervised care that screens, prepares, and follows up. If a difficult experience has left lasting effects, our hallucinogen addiction treatment team can help you make sense of it and move forward.
Radix means root, and that is not just a name. Problematic psychedelic use is almost never the whole story. SAMHSA reports that co-occurring substance use and mental health conditions are common rather than the exception, and in our experience the use is usually standing in for an untreated depression, anxiety disorder, or unprocessed trauma.[2] So we do not refer you out. You get a comprehensive psychiatric evaluation once you are stable, then one team builds one plan.
A psychiatric provider evaluates the depression or anxiety the microdosing was trying to treat, then offers evidence-based, non-addictive medication where it helps. This replaces self-prescribed microdosing with care that is screened, dosed, and monitored.
Cognitive behavioral therapy is the best-evidenced talk therapy for the depression and anxiety that so often sit underneath problematic use. It rebuilds the coping skills that the substance was substituting for, so relief no longer depends on the next trip.
Motivational interviewing meets you where you are. Many people are genuinely unsure whether their use is a problem, and that is normal. MI works with that ambivalence rather than against it, so change comes from you, not from pressure.
When an overwhelming experience leaves persistent anxiety or derealization, trauma-informed therapy gives you a safe place to process it. We help the experience settle into something you can understand and live with, rather than something that keeps intruding.
Because there is no withdrawal window and no taper, treatment moves quickly into the real clinical work. Here is the honest sequence of your first days with us, from the first phone call to the daily work of recovery.
One confidential call to (319) 270-2890. We ask about your psychedelic use, microdosing frequency, any other substances, and your mental health history, and we verify your insurance, all at no cost.
A full psychiatric and substance use evaluation on arrival. If acute anxiety, derealization, or withdrawal from another substance is present, we stabilize that first so the deeper work can begin.
Your therapist and psychiatric provider build a single plan together, not two separate ones. Based on what we find, we recommend residential or intensive outpatient as your entry point.
Daily individual and group therapy, CBT, motivational interviewing, psychiatric follow-up, wellness, and family involvement where you want it, with the same team across every level of care.
When the people treating the use are the same people treating the depression, anxiety, or trauma underneath it, nothing falls through the cracks. The plan is one document, the team is one group of people, and the level of care can change without the relationship changing. That continuity is the difference between addressing the substance and addressing the person.
One plan. One team.
Evidence-based, non-addictive medication for the conditions self-prescribed microdosing was trying to manage.
The best-evidenced talk therapy for the depression and anxiety that sit underneath problematic use.
Meeting genuine ambivalence about whether to stop with respect rather than shame.
Trauma-informed handling of persistent anxiety or derealization left by an overwhelming trip.
Early recovery is steadier inside a residential setting, where nursing, daily medical provider review, and therapy live under one roof in Cedar Rapids. Our entire continuum runs with one clinical team that already knows your story by the time you step down.
All six levels of care one campus in Cedar Rapids, one clinical team.
Most clinical → Independent
Not typically needed for psychedelics alone, only when other substances are involved. If you are also using alcohol, benzodiazepines, or anything else that causes physical withdrawal, our medical team manages that safely first.
The starting point for entangled, polysubstance, or acute psychiatric cases. Structured programming and integrated dual diagnosis care in our restored Higley Mansion facility, with 24/7 support.
Several hours of clinical programming daily with off-site living, a strong middle path as therapy gains traction.
The starting point for microdosing dependence and earlier-stage patterns. Continued therapy and psychiatric care built around work and family, with the same clinical team.
Weekly therapy, relapse prevention, and ongoing mental health care for as long as it helps.
Long-term connection to the alumni community, recovery events, and a team that stays reachable.
Our facility sits in Cedar Rapids, and people come to us from every corner of the state. Stepping away from the group chats, festivals, and social circles where psychedelic use feels normal is often part of what makes change possible, which is why a residential setting can help. Our admissions team coordinates travel, family communication where you want it, and insurance for every Iowa community we serve.
Our Location
~30 min
~1.5 hrs
~1.5 hrs
~1.5 hrs
~10 min
~2 hrs
~2 hrs
~2 hrs
~1.5 hrs
~1 hr
~1 hr
~3.5 hrs
~3 hrs
Move through the facility one room at a time, the living spaces, the gathering rooms, and the grounds where residents reconnect with themselves.
Radix is a listed treatment provider on Your Life Iowa, the official addiction-help resource run by the Iowa Department of Health & Human Services.
Across the Radix clinical leadership team, from the founding partners to the chief clinical officer.
Across client reviews of admissions, counseling, detox, and residential care.
The national standard for safety, treatment quality, and staff training in healthcare.
Not in the classic sense. According to the National Institute on Drug Abuse, classic psychedelics like psilocybin, LSD, and DMT do not produce the compulsive drug-seeking of opioids or stimulants, they do not cause a physical withdrawal syndrome, and tolerance builds so fast that daily use quickly stops working. What is real is psychological dependence: relying on trips or microdoses to cope with depression, anxiety, or daily life. The DSM-5 recognizes problematic use as hallucinogen use disorder, and it is treatable.
Psilocybin, the active compound in psychedelic mushrooms, is not considered physically addictive and does not cause a withdrawal syndrome, and tolerance to it builds rapidly. That does not mean use is always harmless. People can become psychologically dependent on mushrooms, using them to escape or to self-treat depression and anxiety, and use can continue despite anxiety, derealization, or a frightening experience. When that pattern takes hold, treatment helps.
You will not develop the physical addiction seen with opioids or alcohol, and there is no detox to go through. But you can develop a psychological dependence on mushrooms, where they become your main way to cope, escape, or manage a mental health condition, and you keep using despite consequences. That pattern is what the DSM-5 calls hallucinogen use disorder, and we treat it with psychiatric evaluation, therapy, and integrated dual diagnosis care.
Microdosing does not create physical dependence, but it can become a psychological habit that is hard to break. The pattern we see most is escalation: a routine that starts at twice a week drifts into every morning, and skipping a day brings irritability, low mood, or the sense that you cannot focus or cope without it. That reliance, especially when it is masking depression or anxiety, is worth taking seriously and is treatable.
DMT is not considered physically addictive and does not produce a withdrawal syndrome. Its risks lie elsewhere: the experience itself can be overwhelming, and DMT vape pens make a powerful drug available in seconds with no preparation or screening. People can become psychologically reliant on DMT to seek insight or escape, and some are left with lingering anxiety or derealization after an intense trip. Those are the patterns we treat.
Psychedelic dependence is psychological, not physical. It means relying on psilocybin, DMT, or microdosing to function, to escape stress or pain, or to self-medicate depression and anxiety, and continuing despite consequences such as strained relationships or lingering distress. Because there is no physical withdrawal, treatment is not a detox. It is psychiatric evaluation, therapy, and dual diagnosis care that addresses the condition underneath the use.
Most standard drug panels do not test for psilocybin, LSD, or DMT, and these substances clear the body quickly, generally within about 24 hours, though specialized tests can detect them. We share this for safety and honesty, not to help anyone evade testing. If you are using psychedelics to cope, the more useful step is a confidential conversation about what is driving the use and how to address it.
No. Psychedelics do not cause a physical withdrawal syndrome, so there is no detox medication protocol and no taper. Treatment begins with stabilization and a full psychiatric evaluation instead. The exception is polysubstance use: if you are also using alcohol, benzodiazepines, or other substances that do cause physical withdrawal, our medical team manages that safely first, then care moves into therapy and dual diagnosis work.
For most people the effects are temporary, but in predisposed individuals psychedelics can contribute to lasting difficulties, including persistent anxiety, derealization, or, rarely, ongoing perceptual changes, and they can unmask conditions like psychosis or bipolar disorder. This is exactly why clinical trials screen carefully and why unsupervised use carries more risk. If a difficult experience has not fully left you, integrated psychiatric and therapeutic care can help.
In most cases, yes. We are in-network with Wellmark Blue Cross Blue Shield, TriWest Healthcare Alliance, Midlands Choice, Cigna Healthcare, Health Choice, and Medical Associates, and we work with many other plans. Substance use disorder and co-occurring mental health treatment are essential health benefits under federal parity law. Call (319) 270-2890 or use our confidential insurance verification form, and our admissions team will confirm your exact coverage at no cost.